Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodiesSCHROHL, Anne-Sofie; CHRISTIAN PEDERSEN, Hans; STEEN JENSEN, Sussie et al.Histopathology. 2011, Vol 59, Num 5, pp 975-983, issn 0309-0167, 9 p.Article

Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogelKAGEYAMA, Shinichi; KITANO, Shigehisa; OLD, Lloyd J et al.Cancer science. 2008, Vol 99, Num 3, pp 601-607, issn 1347-9032, 7 p.Article

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)NOSKE, A; LOIBL, S; HOFFMANN, G et al.Breast cancer research and treatment. 2011, Vol 126, Num 1, pp 109-117, issn 0167-6806, 9 p.Article

Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancerYANO, Tomonori; DOI, Toshihiko; OHTSU, Atsushi et al.Oncology reports. 2006, Vol 15, Num 1, pp 65-71, issn 1021-335X, 7 p.Article

Analytical validation and interobserver reproducibility of EnzMet GenePro : A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breastDOWNS-KELLY, Erinn; PETTAY, James; HAINFELD, James et al.The American journal of surgical pathology. 2005, Vol 29, Num 11, pp 1505-1511, issn 0147-5185, 7 p.Article

Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lungAWAYA, H; TAKESHIMA, Y; FURONAKA, O et al.Journal of clinical pathology. 2005, Vol 58, Num 10, pp 1076-1080, issn 0021-9746, 5 p.Article

Assessing the Impact of Polysomy-17 on HER2 Status and the Correlations of HER2 Status With Prognostic Variables (ER, PR, p53, Ki-67) in Epithelial Ovarian Cancer: A Tissue Microarray Study Using Immunohistochemistry and Fluorescent In Situ HybridizationLIN, Chih-Kuang; LIN, Wea-Lung; CHEN, Fong-Lin et al.International journal of gynecological pathology. 2011, Vol 30, Num 4, pp 372-379, issn 0277-1691, 8 p.Article

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient CareFABI, Alessandra; DI BENEDETTO, Anna; SPERDUTI, Isabella et al.Clinical cancer research (Print). 2011, Vol 17, Num 7, pp 2055-2064, issn 1078-0432, 10 p.Article

In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissuesAUBELE, M; SPEARS, M; SCHMITT, M et al.British journal of cancer. 2010, Vol 103, Num 5, pp 663-667, issn 0007-0920, 5 p.Article

European Society for Medical Oncology (ESMO) and the European Society for the Cancer Immunology and Immunotherapy (ESCII) International Symposium on ImmunologyCancer immunology and immunotherapy. 2008, Vol 57, Num 10, issn 0340-7004, 1511-1571 [64 p.]Conference Paper

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerLIPTON, Allan; GOODMAN, Laurie; NEWTON, Alicia et al.Breast cancer research and treatment. 2013, Vol 141, Num 1, pp 43-53, issn 0167-6806, 11 p.Article

A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in miceYOUYOU YAN; ZHAO CAO; MING YANG et al.International immunopharmacology (Print). 2012, Vol 12, Num 2, pp 402-407, issn 1567-5769, 6 p.Article

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumabGRELL, Peter; FABIAN, Pavel; KHOYLOU, Marta et al.International journal of oncology. 2012, Vol 41, Num 4, pp 1204-1212, issn 1019-6439, 9 p.Article

In situ detection of HER2:HER2 and HER2:HER3 protein― protein interactions demonstrates prognostic significance in early breast cancerSPEARS, Melanie; TAYLOR, Karen J; MUNRO, Alison F et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 463-470, issn 0167-6806, 8 p.Article

Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerationsLAMBEIN, Kathleen; PRAET, Marleen; FORSYTH, Ramses et al.Journal of clinical pathology. 2011, Vol 64, Num 3, pp 200-207, issn 0021-9746, 8 p.Article

A study of HER2 gene amplification and protein expression in gastric cancerYAN, Benedict; EE XUAN YAU; SITI SHYBA BTE OMAR et al.Journal of clinical pathology. 2010, Vol 63, Num 9, pp 839-842, issn 0021-9746, 4 p.Article

Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progressionOSMAN, Iman; MIKHAIL, Maryann; SHUCH, Brian et al.The Journal of urology. 2005, Vol 174, Num 6, pp 2174-2177, issn 0022-5347, 4 p.Article

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancerVAZQUEZ-MARTIN, Alejandro; COLOMER, Ramon; MENENDEZ, Javier A et al.European journal of cancer (1990). 2007, Vol 43, Num 7, pp 1117-1124, issn 0959-8049, 8 p.Article

Protein kinase Cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplificationMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5308-5317, issn 0008-5472, 10 p.Article

Glassy cell carcinoma of the cervix : Cytologic features and expression of estrogen receptor, progesterone receptor and Her2/neu proteinKURODA, Hajime; TOYOZUMI, Yasuo; MASUDA, Tomoko et al.Acta cytologica. 2006, Vol 50, Num 4, pp 418-422, issn 0001-5547, 5 p.Article

The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast : A fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization studyDOWNS-KELLY, Erinn; YODER, Brian J; STOLER, Mark et al.The American journal of surgical pathology. 2005, Vol 29, Num 9, pp 1221-1227, issn 0147-5185, 7 p.Article

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosisPELLIKAINEN, Johanna M; ROPPONEN, Kirsi M; KATAJA, Vesa V et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7621-7628, issn 1078-0432, 8 p.Article